|Bid||63.85 x 800|
|Ask||64.30 x 900|
|Day's Range||62.75 - 64.38|
|52 Week Range||56.07 - 109.42|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||9.91|
|Earnings Date||May 19, 2020 - May 24, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 09, 2018|
|1y Target Est||94.00|
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
If you own shares in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) then it's worth thinking about how it contributes...
TARO PHARMACEUTICALS U.S.A. ISSUES VOLUNTARY NATIONWIDE RECALL OF PHENYTOIN ORAL SUSPENSION USP, 125 MG/5 ML
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) shares fell 5.9% to US$77.45 in the week since its latest...
Taro Pharmaceutical Industries Ltd (NYSE: TARO) former Vice President of Sales and Marketing Ara Aprahamian has been indicted by the Justice Department for price-fixing and bid-rigging on Tuesday, Reuters reported. According to the Justice Department, a federal grand jury in the US District Court for the Eastern District of Pennsylvania has indicted Aprahamian for his role to fix prices, rig bids, and allocate customers for generic drugs, and for making a false statement to federal agents who were investigating those conspiracies.
Taro (TARO) delivered earnings and revenue surprises of 14.29% and -14.14%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
While it may not be enough for some shareholders, we think it is good to see the Taro Pharmaceutical Industries Ltd...
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]
In this article we are going to estimate the intrinsic value of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by...
Taro (TARO) delivered earnings and revenue surprises of -15.12% and -4.60%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Taro (TARO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]